col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


80 Ergebisse       Seite 1

 [1] 
Elsevier: Journal of Global Antimicrobial Resistance
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―29 Enterobacter roggenkampii producing KPC-3 collected from a hospital sink drain in Portugal during the COVID-19 pandemic Gabriel Mendes, Maria Leonor Santos, João F. Ramalho, Aida Duarte, Adriana Pedrosa, Ana Cristina Silva, et al. (+2)
2 [GO] 2025―Apr―26 Impact of COVID-19 on epidemiology and mortality risk factors in patients with carbapenem-resistant Acinetobacter baumannii bloodstream infections in a tertiary care hospital in Thailand Darunee Chotiprasitsakul, Korchart Ao-udomsuk, Pitak Santinirand
3 [GO] 2025―Jan―14 Drug-resistant tuberculosis is an important challenge in long COVID patients Masoud Mohammadi, Seyed Hassan Faghihi
4 [GO] 2024―Dez―27 Potential drug interaction after withdrawal of nirmatrelvir-ritonavir in hospitalized patients with COVID-19 infection Yun Han, Yonglan Gou, Jieqiong Liu, Lingyan Yu, Yuhua Zhao, Zhenwei Yu
5 [GO] 2024―Dez―26 EFFICACY OF HMG-CoA REDUCTASE INHIBITORS IN COVID-19 PATIENTS MORTALITY RATE: A META-ANALYSES OF RANDOMIZED CONTROL TRIALS Mohammadreza Shafiei, Mohammadamin Keykhah
6 [GO] 2024―Dez―26 Evaluation of the impact of the COVID-19 pandemic on treatment response of newly diagnosed people living with HIV: Turkey experience Çiğdem ATAMAN HATİPOĞLU, Halis Akalın, Serhat Ünal, Meliha Çağla Sönmezer, Volkan Korten, Buket Ertürk Şengel, et al. (+39)
7 [GO] 2024―Dez―26 Changes in epidemiology of respiratory viruses after COVID-19 pandemic in Daegu City and Gyeongsangbuk-do Province, Korea Ji Jung Kim, Hyeok Gyu Kwon, Hee Ju Lim, Sang Bong Han
8 [GO] 2024―Dez―26 Multidrug-resistant Organisms Among Patients in COVID-19 Wards Compared to Non-COVID-19 Wards in Indonesian Hospitals Shod A. Zulkarnain, Radhitya Abdullah, Ardellia G. Pradnyadevati, Muhammad FR Roesianto, Oktavia K. Putri, Raden BR Padmosudiro, et al. (+13)
9 [GO] 2024―Dez―26 The influence of COVID-19 on the incidence and antimicrobial resistance of multi-drug resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii in a tertiary care hospital in Belgrade (Serbia) Predrag Savic, Milos Gostimirovic, Teodora Vitorovic, Jovana Rajkovic, Ana Bukarica, Ljiljana Gojkovic-Bukarica
10 [GO] 2024―Dez―26 The influence of COVID-19 on the antibiotic consumption in a tertiary care hospital in Belgrade (Serbia) Milos Gostimirovic, Predrag Savic, Teodora Vitorovic, Jovana Rajkovic, Ana Bukarica, Ljiljana Gojkovic Bukarica
11 [GO] 2024―Dez―26 Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers of COVID-19 irrespective of patients immunosuppression status: a case-control retrospective single-center study Amalia Papanikolopoulou, Eftychia Eirini Maria Gourdoupari, Polyxeni Alexiou, Charalampos Charalampous, Vasiliki Rapti, Maria Effrosyni Livanou, et al. (+4)
12 [GO] 2024―Dez―26 Factors associated with the functional health and well-being of Singapore residents living with the covid-19 endemic Zhilian Huang, Kangwei Zeng, Hwee Pin Phua, Chia Siong Wong, Mark I-Cheng Chen
13 [GO] 2024―Dez―26 Aggravating factors and post COVID-19 conditions in COVID-19 patients complicated with autoimmune rheumatic diseases Yoshihiko Ikeno, Fumiya Fukushima, Azusa Kikuchi, Ryouta Koike, Masafumi Arima, Kazuhiro Kurasawa, Kei Ikeda
14 [GO] 2024―Dez―26 Insights from One of the Largest COVID-19 Cohorts: A Detailed Analysis of Risk Factors, Mortality Predictors, and Vaccine Efficacy in Istanbul Şiran Keske, Selin Kolsuz, Anı Akpınar, Mahir Kapmaz, Süda Tekin, Bahar Kaçmaz, et al. (+8)
15 [GO] 2024―Dez―26 Impact of Pre-Existing Comorbidities and Multimorbidities, Demography and Viral Variants on Post-Acute Sequelae of COVID-19 (‘Long COVID’) in Dutch Primary Care: A Retrospective Cohort Study Matthijs S Berends, Maarten Homburg, Thijmen Kupers, Eline N Meijer, Isabelle Bos, Robert Verheij, et al. (+3)
16 [GO] 2024―Dez―26 Prolonged acute inflammatory responses of colonic epithelial cells to SARS-CoV-2 spike protein: implications for gastrointestinal manifestations in COVID-19 Aysegul Yilmaz, Sevilay Tura, Seyhan Turk, Can Türk
17 [GO] 2024―Dez―26 Prognostic cut-off values of neutrofil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for COVID-19: a case-control retrospective single-center study Amalia Papanikolopoulou, Eftychia Eirini Maria Gourdoupari, Charalampos Charalampous, Polyxeni Alexiou, Vasiliki Rapti, Maria Effrosyni Livanou, et al. (+4)
18 [GO] 2024―Dez―26 Possible cross protection between influenza and COVID-19: evidence from a pilot review of national surveillance data Muhammad Aqmal Bin Mohamad Haris, Smeetha Nair, Jillian Shu En Khoo, Paul Anantharajah Tambyah
19 [GO] 2024―Dez―26 Evaluation of The Anti-Viral Response Against SARS-CoV-2 Omicron Variant Appeared In The First Half of 2024 in Healthcare Workers Using In Vitro Cell Culture Model Arzuhan Buyuker, Aynur Karadenizli, Emel Azak, Rana Topal
20 [GO] 2024―Dez―26 SARS-CoV-2 Still on the Stage: The Need to Pursue an Integrated Respiratory Virus Surveillance Mine Durusu Tanriover, Ayşe Tülay Bağcı Bosi, Lale Ozisik, Fırat Şırvan, Tuğçenur Müderrisoğlu, Oğuz Abdullah Uyaroğlu, et al. (+14)
21 [GO] 2024―Nov―26 Amikacin, in combination with cations, prevents growth of a carbapenem-resistant/multidrug-resistant Klebsiella pneumoniae strain isolated from a patient with COVID-19 Angel J. Magaña, David Ngo, Diego Faccone, Sonia Gomez, Alejandra Corso, Fernando Pasteran, et al. (+2)
22 [GO] 2024―Mai―23 A Scoping Review of Bacterial Resistance Among Inpatients Amidst the COVID-19 Pandemic Noora Reffat, Rebecca J Schwei, Meggie Griffin, Aurora Pop-Vicas, Lucas T Schulz, Michael S Pulia
23 [GO] 2024―Mai―07 Clinical characteristics and risk factors for bacterial co-infections in COVID-19 patients: A retrospective study Yichuan Gan, Guowen Zhang, Hengbiao Sun, Xiaoming Lyu
24 [GO] 2024―Mrz―27 When it rains it pours: an increased prevalence of intestinal carriage of vancomycin-resistant Enterococcus faecium related to higher use of oral vancomycin in a tertiary care Hungarian clinical center during the years of the COVID-19 pandemic László Orosz
25 [GO] 2024―Mrz―07 Changes in antimicrobial resistance of Escherichia coli isolated from community associated urinary tract infection before and during the COVID-19 pandemic in India Shwetha Venugopal, Sneha Chunchanur, Rajashree Panigrahy, Vibhor Tak, Manish Yadav, Akanksha Chauhan, et al. (+9)
26 [GO] 2024―Jan―26 Genomic surveillance of carbapenem-resistant Klebsiella pneumoniae reveals a prolonged outbreak of extensively drug-resistant ST147 NDM-1 during the COVID-19 pandemic in the Apulia region (Southern Italy) Daniela Loconsole, Anna Sallustio, Davide Sacco, Marilina Santantonio, Daniele Casulli, Domenico Gatti, et al. (+6)
27 [GO] 2024―Jan―03 An Evaluation of the Five Rights Antibiotic Safety Before and During COVID-19 at an NHS Foundation Trust in the United Kingdom Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour
28 [GO] 2023―Aug―22 Co-infection in COVID-19 patients performed microbiology detection: discovering multi-drug resistant microorganisms increased during the COVID-19 pandemic in Shanghai, China Xin Jin, Liyan Zeng, Lijun Zhang, Zhaoqin Zhu
29 [GO] 2023―Apr―13 Corrigendum to “Antibiotic expectation, behaviour, and receipt among patients presenting to emergency departments with uncomplicated upper respiratory tract infection during the COVID-19 pandemic” [Journal of Global Antimicrobial Resistance 33 (2023) 89-96] Zhilian Huang, Win Sen Kuan, Hann Yee Tan, Eillyne Seow, Ling Tiah, Li Lee Peng, et al. (+2)
30 [GO] 2023―Mrz―10 Antibiotic expectation, behaviour, and receipt among patients presenting to emergency departments with uncomplicated upper respiratory tract infection during the COVID-19 pandemic Zhilian Huang, Win Sen Kuan, Hann Yee Tan, Eillyne Seow, Ling Tiah, Li Lee Peng, et al. (+2)
31 [GO] 2022―Dez―23 Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial Florian Kurth, Elisa T. Helbig, Lena J. Lippert, Charlotte Thibeault, Gianluca Barbone, Marius A. Eckart, et al. (+12)
32 [GO] 2022―Dez―19 61: SECONDARY INFECTION DURING THE THIRDWAVE OF COVID-19 IN A HOSPITAL IN KATHMANDU S.K. Mishra Baishnab
33 [GO] 2022―Dez―19 WS1.3: DETERMINANTS OF ANTIBIOTIC EXPECTATION AND RECEIPT AMONG PATIENTS PRESENTING TO EMERGENCY DEPARTMENTS WITH UPPER RESPIRATORY TRACT INFECTION DURING THE COVID-19 PANDEMIC Zhilian Huang, Angela Chow
34 [GO] 2022―Dez―19 WS1.2: USE OF ANTIBIOTICS IN COVID-19 PATIENTS AND ANTIBACTERIAL RESISTANCE PATTERN- A COUNTRYWIDE PICTURE Shrebash Paul, Tabiha Binte Hannan, T.M. Al-Amin, Md. Mohiuddin Khan, Binayak Bhattacharjee, Md. Zainal Abedin, et al. (+6)
35 [GO] 2022―Dez―19 63: A MICROBIOLOGICAL RETROSPECTIVE REVIEW OF BLOOD STREAM INFECTIONS IN COVID-19 PATIENTS FROM A TERTIARY CARE CENTER IN LEBANON S. Nahhal, N. Zahreddine, J. Tannous, N. Haddad, J. Zakhour, A. Shmoury, et al. (+3)
36 [GO] 2022―Dez―19 64: BACTERIAL RESPIRATORY INFECTIONS IN PATIENTS WITH COVID-19: A RETROSPECTIVE STUDY FROM A TERTIARY CARE CENTER IN LEBANON A. Shmoury, T. Sawma, S.F. Haddad, N. Zahreddine, J. Tannous, J. Zakhour, et al. (+2)
37 [GO] 2022―Dez―19 54: THE IMPACT OF THE CORONAVIRUS DISEASE PANDEMIC ON RESPIRATORY-RELATED INFECTIONS IN JAPAN D. Kitagawa, T. Kitano, M. Furumori, S. Suzuki, Y. Shintani, A. Nishiyama, et al. (+9)
38 [GO] 2022―Dez―19 58: SARS-COV-2 ANTIBODY CHARACTERISTICS OF SALIVA FROM VACCINATED INDIVIDUALS K. Ota, F. Mitsumoto-Kaseida, K. Sakamoto, K. Kosai, H. Hasegawa, K. Yamamoto, et al. (+4)
39 [GO] 2022―Dez―19 69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER M.V.R. Macatangay, J.A. Buensalido
40 [GO] 2022―Dez―01 Effect of Farnesyltransferase Inhibitors on SARS-CoV-2 Lea Weber, Lena Mautner, Mona Hoyos, Anja Ehrhardt, Armin Baiker, Hagen Sjard Bachmann
41 [GO] 2022―Nov―08 Replacement of KPC-producing pandemic lineages and dissemination of plasmids associated to antimicrobial resistance determinants during inpatient´s hospitalization Verónica E. Álvarez, Natalia García Allende, Mariana G. Massó, María Piekar, Josefina Campos, Barbara Fox, et al. (+4)
42 [GO] 2022―Okt―05 In vitro activity of ceftazidime/avibactam against carbapenem-non-susceptible Klebsiella penumoniae isolates collected during SARS-CoV-2 pandemic: a Southern Italy, multi-center, surveillance study Gianfranco La Bella, Teresa Lopizzo, Laura Lupo, Rosa Angarano, Anna Curci, Barbara Manti, et al. (+4)
43 [GO] 2022―Jun―13 Overuse of empirical antibiotics in a Covid-19 intensive care unit led to the spread of carbapenem-resistant Gram-negative bacteria in a teaching hospital Daniela Dambroso-Altafini, Silvia Maria dos Santos Saalfeld, Monica de Souza Ferreira de Mattos, Hilton Vizzi Martinez, Danielle Rosani Shinohara, Mirian Nicéa Zarpellon, et al. (+2)
44 [GO] 2022―Feb―25 Preexisting conditions among the SARS-CoV2 deaths during the SARS-CoV2 B.1.617.2 (Delta variant) outbreak in the United Kingdom Venkata R. Emani, Raghunath Reddy, Kartik K. Goswami, Abirath S. Nakka, Shaila R. Emani, Nikhila K. Reddy, et al. (+3)
45 [GO] 2022―Jan―14 In vitro evaluation of virucidal activity of disodium citrate perhydrate (2SCP) disinfectant against SARS-CoV-2 virus Géraldine Dessilly, Anne-thérèse Pâques, Anne-thérèse Vandenbroucke, Pierre Hazée, Alain Gaume, Katia Gindro, et al. (+3)
46 [GO] 2021―Nov―12 Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy Briony Adams, Alec Beaney
47 [GO] 2021―Nov―04 COVID-19 disease severity is linked to host immunity as well as lung and gut dysbiosis: a narrative review Nobuhiro Asai, Hiroshige Mikamo
48 [GO] 2021―Okt―28 Repatriation of patient with COVID-19 contributed to the importation of an emerging carbapenemase producer Aline I. Moser, Edgar I. Campos-Madueno, Parham Sendi, Vincent Perreten, Peter M. Keller, Alban Ramette, Andrea Endimiani
49 [GO] 2021―Sep―22 Successful prolonged cefiderocol treatment of a chronic left pleural empyema caused by Pseudomonas aeruginosa in a patient affected by COVID-19: a case report Luca Borghesi, Valentina Viaggi, Marco Franzetti, Matteo Montoli, Carola Mauri, Giovanni Moioli, et al. (+3)
50 [GO] 2021―Sep―04 Shortage in Appropriate Diagnostics of Antimicrobial Resistance in Lebanese Clinical Settings: A Crisis Amplified by COVID-19 and Economic Collapse Marwan Osman, Dalal Kasir, Issmat I. Kassem, Monzer Hamze
51 [GO] 2021―Jul―15 Loss of Function Mutations in the IFNAR2 in COVID-19 Severe Infection Susceptibility Sandra P. Smieszek, Mihael H. Polymeropoulos
52 [GO] 2021―Jul―07 Vaccine or Monoclonal therapy: which is winning weapon against COVID-19? Lorenzo Lo Muzio, Maria Eleonora Bizzoca
53 [GO] 2021―Jun―09 What prompts clinicians to start antibiotic treatment in COVID-19 patients? An Italian web-survey helps us understand where the doubts lie Marta Colaneri, Pietro Valsecchi, Marco Vecchia, Alessandro Di Filippo, Valentina Zuccaro, Elena Seminari, et al. (+6)
54 [GO] 2021―Mai―27 Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses Jeswin Joseph, T. Karthika, V.R. Akshay Das, V. Stalin Raj
55 [GO] 2021―Mrz―01 AMR research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic Jesús Rodríguez-Baño, Gian Maria Rossolini, Constance Schultsz, Evelina Tacconelli, Srinivas Murthy, Norio Ohmagari, et al. (+17)
56 [GO] 2021―Mrz―01 Genomic Data Reveals the Emergence of IncQ1 Small Plasmid Carrying blaKPC-2 in Escherichia coli of the Pandemic Sequence Type 648 Bruna Fuga, Louise Cerdeira, Quézia Moura, Herrison Fontana, Danny Fuentes-Castillo, Albalúcia C. Carvalho, Nilton Lincopan
57 [GO] 2021―Jan―18 Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2 Alasdair MacGowan, Fergus Hamilton, Mark Bayliss, Liam Read, Marie Attwood, Alan Noel, et al. (+4)
58 [GO] 2020―Dez―29 Antiviral activity of interferon-based combination therapy in critically ill patients with Covid-19: preliminary observations Paolo Gaibani, Tommaso Tonetti, Michele Bartoletti, Maria Carla Re, PierLuigi Viale, V. Marco Ranieri
59 [GO] 2020―Dez―25 Treatment of a case with COVID-19 administering intravenous immunoglobulin Mustafa Çolak, Serdar Kalemci, Aydın Sarıhan
60 [GO] 2020―Dez―08 A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19) Sock Hoon Tan, Tat Ming Ng, Hui Lin Tay, Min Yi Yap, Shi Thong Heng, Audrey Yong Xin Loo, et al. (+2)
61 [GO] 2020―Dez―08 Remdesivir for the treatment of coronavirus COVID-19: a meta-analysis of randomised controlled trials Yuki Enoki, Yuki Igarashi, Yuki Watabe, Kyoka Honma, Yuto Suzuki, Yukitaka Hayashi, et al. (+3)
62 [GO] 2020―Nov―23 Cytokine storm of a different flavor: the different cytokine signature of SARS-CoV2 the cause of COVID-19 from the original SARS outbreak Daniel O. Griffin, Alexandra Jensen, Mushmoom Khan, Jessica Chin, Kelly Chin, Jennifer Saad, et al. (+3)
63 [GO] 2020―Nov―23 Carbapenem resistant Klebsiella pneumoniae in ICU-admitted COVID-19 Patients: Keep an eye on the ball G. Montrucchio, S. Corcione, G. Sales, A. Curtoni, F.G. De Rosa, L. Brazzi
64 [GO] 2020―Okt―29 INCIDENCE OF BACTERIAL AND FUNGAL BLOODSTREAM INFECTIONS IN COVID-19 PATIENTS IN INTENSIVE CARE: AN ALARMING “COLLATERAL EFFECT” Maria Adriana Cataldo, Nardi Tetaj, Marina Selleri, Luisa Marchioni, Alessandro Capone, Emanuela Caraffa, et al. (+2)
65 [GO] 2020―Okt―17 Ototoxicity prevention during the SARS-CoV-2 (Covid-19) emergency Andrea Ciorba, Piotr Henryk Skarżyński, Stefano Pelucchi, Stavros Hatzopoulos
66 [GO] 2020―Okt―13 A Possible Application of High Dose Vitamin C in the Prevention and Therapy for Coronavirus Infections Ba X. Hoang, D. Graeme Shaw, William Fang, Bo Han
67 [GO] 2020―Aug―20 A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: results of a retrospective observational study in the French overseas department of Reunion Island Arthur Dubernet, Kevin Larsen, Laurie Masse, Jérôme Allyn, Emilie Foch, Lea Bruneau, et al. (+14)
68 [GO] 2020―Aug―15 Neutrophil-to-lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients Shaghayegh Haghjooy Javanmard, Golnaz Vaseghi, Amir Reza Manteghi Nezhad, Maryam Nasirian
69 [GO] 2020―Aug―15 Usefulness of brochoalveolar lavage in suspect covid-19 repeatedly negative swab test and interstitial lung disease Jacopo Vannucci, Franco Ruberto, Daniele Diso, Gioacchino Galardo, Claudio M. Mastroianni, Giammarco Raponi, et al. (+6)
70 [GO] 2020―Aug―08 Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-COV-2 infection? Sudhir Mehta, Sudhir Bhandari, Shaurya Mehta
71 [GO] 2020―Aug―05 Hydroxychloroquine use in Hospitalized Patients with COVID-19: An observational matched cohort study Markos Kalligeros, Fadi Shehadeh, Eleftheria Atalla, Evangelia K. Mylona, Su Aung, Aakriti Pandita, et al. (+7)
72 [GO] 2020―Jul―25 Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care Lesley Heesom, Lucas Rehnberg, Myra Nasim-Mohi, Alexander I.R. Jackson, Michael Celinski, Ahilanadan Dushianthan, et al. (+3)
73 [GO] 2020―Jul―16 Could Bordetella pertussis vaccine protect against coronavirus COVID-19? Usama M. Alkholy, Mohamed E Salama, Hagar Mahmoud, Ahmed Taher, Khaled M. Elsayes
74 [GO] 2020―Jul―11 Perceived Challenges of COVID-19 Infection Prevention and Control Preparedness: A Multinational Survey Ermira Tartari, Joost Hopman, Benedetta Allegranzi, Bin Gao, Andreas Widmer, Vincent Chi-Chung Cheng, et al. (+4)
75 [GO] 2020―Jul―02 SARS-CoV-2 positivity in rectal swabs implication for possible transmission Federica Novazzi, Irene Cassaniti, Antonio Piralla, Antonio Di Sabatino, Raffaele Bruno, Fausto Baldanti
76 [GO] 2020―Jul―01 Azithromycin and SARS-CoV-2 infection: where we are now and where we are going Luis Gabriel Parra-Lara, Juan José Martínez-Arboleda, Fernando Rosso
77 [GO] 2020―Jun―12 The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic Anuradha Chowdhary, Amit Sharma
78 [GO] 2020―Mai―29 Vitamin D deficiency and COVID-19 pandemic Patrick Zemb, Peter Bergman, Carlos A. Camargo, Etienne Cavalier, Catherine Cormier, Marie Courbebaisse, et al. (+7)
79 [GO] 2020―Apr―27 Continues Renal Replacement Therapy (CRRT) With Disposable Hemoperfusion Cartridge: A Promising Option for Severe COVID-19 Farzaneh Dastan, Ali Saffaei, Seyed Mehdi Mortazavi, Hamidreza Jamaati, Nadia Adnani, Sasan Samiee Roudi, et al. (+3)
80 [GO] 2020―Mrz―07 2019-novel coronavirus outbreak: A new challenge Tommaso Lupia, Silvia Scabini, Simone Mornese Pinna, Giovanni Di Perri, Francesco Giuseppe De Rosa, Silvia Corcione
 [1] 

80 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec